# Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease

> **NCT03594656** · PHASE3 · UNKNOWN · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 288 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Ganoderma
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03594656
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-15
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 288 (ESTIMATED)
- **Last updated:** 2021-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03594656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03594656, "Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03594656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*